Are you Dr. Goldblum?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 91 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
9500 Euclid Ave
Cleveland, OH 44195Phone+1 800-223-2273Fax+1 216-445-2142
Summary
- Dr. John Goldblum, MD is a board certified pathologist in Cleveland, Ohio. He is currently licensed to practice medicine in Ohio, Nevada, and Pennsylvania. He is affiliated with Cleveland Clinic, VA Northeast Ohio Healthcare System, and Cleveland Clinic South Pointe Hospital.
Education & Training
University of MichiganResidency, Pathology-Anatomic and Clinical, 1989 - 1993
University of Michigan Medical SchoolClass of 1989
Certifications & Licensure
OH State Medical License 1993 - 2027
MI State Medical License 1990 - 2026
WA State Medical License 2013 - 2026
WV State Medical License 2013 - 2026
CA State Medical License 2013 - 2025
CO State Medical License 2013 - 2025
FL State Medical License 2012 - 2025- American Board of Pathology Anatomic Pathology
- Join now to see all
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2006-2014
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- Top MD Consumers Checkbook
Publications & Presentations
PubMed
- 108 citationsT-Helper 2 Cytokines, Transforming Growth Factor β1, and Eosinophil Products Induce Fibrogenesis and Alter Muscle Motility in Patients With Eosinophilic EsophagitisFlorian Rieder, Ilche T. Nonevski, Jie Ma, Zhufeng Ouyang, Gail West
Gastroenterology. 2014-05-01 - 37 citationsSuperficial ALK-rearranged myxoid spindle cell neoplasm: a cutaneous soft tissue tumor with distinctive morphology and immunophenotypic profile.Josephine K Dermawan, Elizabeth M Azzato, John R. Goldblum, Brian P. Rubin, Steven D. Billings
Modern Pathology. 2021-06-04 - 83 citationsEvaluation of the usefulness of testing for p53 mutations in colorectal cancer surveillance for ulcerative colitis.Bret A. Lashner, Bradley D. Shapiro, Asif Husain, John R. Goldblum
The American Journal of Gastroenterology. 1999-02-01
Press Mentions
Research Validates Tissue Pathology Test Predicting Progression in Barrett’s EsophagusMay 21st, 2019
Wheat, Wheat, Don’t Tell Me!July 26th, 2017- Well-Differentiated Lipomatous Tumors: A Case Series (Video)July 14th, 2017
- Join now to see all
